AVIARADX, INC. - Patents
AVIARADX, INC. SAN DIEGO, CA US 1. 20090092973 Grading of Breast Cancer - Methods and compositions for the identification of breast cancer grade signatures are provided 04-09-2009
Covington & Burling LLP | News & Events | Covington Advises ...
BioMérieux plans to keep AviaraDx as an independent legal entity called bioTheranostics, Inc. ... Advises bioMérieux on AviaraDx Acquisition. Offices Contact Us ...
News: bioMerieux Gains Critical Oncology and Theranostics ...
bioMerieux, a world leader in the field of in vitro diagnostics has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, based in ...
bioMerieux SA acquires AviaraDx Inc from SDL Capital LP (2008 ...
Deal Information, Thomson M&A: bioMerieux SA acquires AviaraDx Inc from SDL Capital LP (2008/09/11) - AlacraStore.com ... SA acquired AviaraDx Inc, a ...
Regional Sales Account Manager, Molecular Oncology ...
bioTheranostics, Inc. (formerly AviaraDx), a bioMerieux company based in San Diego, CA, develops and commercializes high value molecular diagnostic test
AviaraDx Confirms That Combination Of Two Molecular ...
AviaraDx, Inc. ... AviaraDx discovers, develops, and commercializes new molecular diagnostic tests ... AviaraDx offers these diagnostic tests to qualified ...
BioMerieux Spends $60M to Acquire Private Molecular Dx Firm ...
San Diego-based AviaraDx makes tests — the CancerTYPE ID and Breast Cancer ... BioMerieux said that AviaraDx "has limited sales today and is projected to lose ...
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in ...
From AviaraDx Inc, Carlsbad, CA; The Breast Center, Baylor College of Medicine, ... PhD, 2715 Loker Ave W, Carlsbad, CA 92008; e-mail: merlander{at}aviaradx.com ...
Covington & Burling LLP | News & Events | Covington Advises ...
SAN FRANCISCO, CA, September 18, 2008 — BioMérieux announced that it has signed an agreement to acquire privately held AviaraDx, Inc. for $60 million. BioMérieux plans to keep ...
News: Novel Two-Gene Ratio Found to Be a Prognostic Indicator of ...
AviaraDx reported that a study conducted in collaboration with Baylor College of Medicine further demonstrated the clinical utility of two novel genes for the identification of pat
AviaraDx, Inc. Announces Publication of Study With Baylor ...
AviaraDx discovered both biomarkers in a collaborative study with Harvard ... AviaraDx has licensed its technologies for specific clinical indications to ...
Center for Molecular Medicine Partners with AviaraDx to Offer ...
Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment Tests Improve Cancer Identification, Help ...
bioMerieux Acquires Oncology and Theranostics Company ...
The acquisition of AviaraDx will help bioMérieux gain validated cancer ... AviaraDx has two innovative products on the market based on proprietary ...
AviaraDx - WikiCover
AviaraDx discovers, develops, and commercializes new molecular diagnostic tests ... AviaraDx offers diagnostic tests to qualified physicians or laboratories through ...
AviaraDx, Inc. And Massachusetts General Hospital Collaborate ...
AviaraDx, Inc., a leader inmolecular cancer profiling and formerly known as Arcturus Bioscience, Inc.,announced today that it has entered into a major research ...
AviaraDx, Inc., Formerly Arcturus Bioscience, Inc., Announces ...
AviaraDx technologies and intellectual properties position the company to ... AviaraDx has relocated its headquarters from Mountain View, California to Carlsbad, ...
BioMerieux buys AviaraDx for $60 mln | Reuters
PARIS, Sept 11 (Reuters) - French in-vitro diagnostics firm bioMerieux <BIOX.PA> said on Thursday it bought privately held AviaraDx, Inc., based in San Diego, ...
Government Buyers Guide - Computer Software Supplies and Products ...
NEWS about new products and services: Company Details: AviaraDx announces CAP accreditation of its laboratory operations: AviaraDx announced today that the company's Carlsbad, CA ...
AviaraDx, Inc. Announces Appointment Of Mary Barry To Vice ...
CARLSBAD, Calif., July 26 /PRNewswire/ -- AviaraDx, Inc., a molecular cancer profiling company enabling personalized medicine in oncology, announced today that Mary Barry, MT (ASCP ...
H/I ratio predicts failure to tamoxifen therapy in recurrent breast ...
AviaraDx has licensed its technologies for specific clinical indications to reference laboratories in the United States and Europe. Please visit the AviaraDx website at https://www ...
